|1.||Durrant, L G: 4 articles (08/2008 - 02/2000)|
|2.||Maxwell-Armstrong, Charles: 2 articles (12/2006 - 09/2002)|
|3.||Carmichael, J: 2 articles (06/2001 - 02/2000)|
|4.||Robins, R A: 2 articles (06/2001 - 02/2000)|
|5.||Scholefield, J H: 2 articles (06/2001 - 02/2000)|
|6.||Kallmeyer, C: 1 article (08/2008)|
|7.||Ullenhag, G J: 1 article (08/2008)|
|8.||Watson, N F S: 1 article (08/2008)|
|9.||Spendlove, I: 1 article (08/2008)|
|10.||Pritchard-Jones, K: 1 article (08/2008)|
|1.||Colorectal Neoplasms (Colorectal Cancer)
12/15/2006 - "A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55."
09/01/2002 - "Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer."
06/01/2001 - "Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer."
02/01/2000 - "A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55."
10/01/1999 - "Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7."
01/01/1995 - "Clinical evidence that the human monoclonal anti-idiotypic antibody 105AD7, delays tumor growth by stimulating anti-tumor T-cell responses."
09/15/1994 - "Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7."
09/04/1991 - "These findings show that the human monoclonal anti-idiotypic antibody 105AD7 is likely to induce cellular immune responses to tumors in cancer patients."
10/01/2000 - "The human anti-idiotypic antibody 105AD7 was isolated from a colorectal cancer patient receiving the anti-tumor antibody 791T/36 for radioimmuno-scintigraphy of liver metastases. "
|3.||Osteosarcoma (Osteogenic Sarcoma)
|4.||Neoplasm Metastasis (Metastasis)
|2.||aluminum sulfate (alum)